NVNO
enVVeno Medical Corp
NASDAQ: NVNO · HEALTHCARE · MEDICAL DEVICES
$10.50
+0.57% today
Updated 2026-05-01
Market cap
$7.81M
P/E ratio
—
P/S ratio
216.91x
EPS (TTM)
$-33.06
Dividend yield
—
52W range
$9 – $197
Volume
0.0M
enVVeno Medical Corp (NVNO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-56.20%
ROA
-35.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $236500.00 | $-1.40M | -12.66% | -402.82% | -591.12% |
| 2015 | — | $-1.60M | — | — | — |
| 2016 | $785912.00 | $-5.89M | -22.34% | -592.84% | -749.01% |
| 2017 | $422111.00 | $-7.79M | -32.40% | -1,445.89% | -1,845.83% |
| 2018 | $186552.00 | $-13.04M | 100.00% | -4,210.51% | -6,991.46% |
| 2019 | $31243.00 | $-7.63M | 100.00% | -24,566.50% | -24,406.74% |
| 2020 | $0.00 | $-9.14M | — | — | — |
| 2021 | $0.00 | $-16.53M | — | — | — |
| 2022 | $0.00 | $-24.67M | — | — | — |
| 2023 | $0.00 | $-23.52M | — | — | — |
| 2024 | $0.00 | $-21.82M | — | — | — |
| 2025 | $0.00 | $-19.47M | — | — | — |